首页> 美国卫生研究院文献>Clinical Kidney Journal >Adenine phosphoribosyltransferase (APRT) deficiency: a new genetic mutation with early recurrent renal stone disease in kidney transplantation
【2h】

Adenine phosphoribosyltransferase (APRT) deficiency: a new genetic mutation with early recurrent renal stone disease in kidney transplantation

机译:腺嘌呤磷酸核糖基转移酶(APRT)缺陷:肾移植中早期复发肾结石病的一种新的基因突变。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adenine phosphoribosyltransferase (APRT) deficiency, a rare inborn error inherited as an autosomic recessive trait, presents with 2,8-dihydroxyadenine (2,8-DHA) crystal nephropathy. We describe clinical, biochemical and molecular findings in a renal transplant recipient with renal failure, 2,8-DHA stones and no measurable erythrocyte APRT activity. Homozygous C > G substitution at −3 in the splicing site of exon 2 (IVS2 −3 c > g) was found in the APRT gene. The patient’s asymptomatic brother was heterozygous for such mutation, and his APRT activity was 23% of controls. A splicing alteration leading to incorrect gene transcription and virtually absent APRT activity is seemingly associated with the newly identified mutation.
机译:腺嘌呤磷酸核糖基转移酶(APRT)缺乏症是一种罕见的先天性遗传,是常染色体隐性遗传,它伴有2,8-二羟基腺嘌呤(2,8-DHA)结晶性肾病。我们描述了肾衰竭,2,8-DHA结石且无可测量的红细胞APRT活性的肾移植受者的临床,生化和分子发现。在APRT基因中发现外显子2剪接位点处的纯合C> G取代(IVS2 -3 c> g)。患者的无症状兄弟是这种突变的杂合子,其APRT活性为对照组的23%。新发现的突变似乎与导致基因转录错误和APRT活性实际上不存在的剪接改变有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号